articleScienceSep 14, 2017GREEN OA

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

Weizmann Institute of Science · Broad Institute · +16 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Expression, and abrogated by cotreatment with the antibiotic ciprofloxacin. Gemcitabine is commonly used to treat pancreatic ductal adenocarcinoma (PDAC), and we hypothesized that intratumor bacteria might contribute to drug resistance of these tumors. Consistent with this possibility, we found that of the 113 human PDACs that were tested, 86 (76%) were positive for bacteria, mainly Gammaproteobacteria.

Citation impact

1,740
total citations
FWCI
40.59
Percentile
100%
References
30
Citations per year

Authors

47

Topics & keywords

Keywords
  • Gemcitabine
  • Drug resistance
  • Drug
  • Bacteria
  • Chemotherapeutic drugs
  • Cancer research
  • Biology
  • Pharmacology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding